Classification of anti-HIV compounds using counterpropagation artificial neural networks and decision trees
- 1 October 2011
- journal article
- research article
- Published by Taylor & Francis in SAR and QSAR in Environmental Research
- Vol. 22 (7-8) , 639-660
Abstract
The main aim of the present work was to collect and categorize anti-HIV molecules in order to identify general structure–activity relationships. In this respect, a total of 5580 drugs and drug-like molecules was collected from 256 different articles published between 1992 and 2010. An algorithm called genetic algorithm–pattern search counterpropagation artificial neural networks (GPS-CPANN) was proposed for the classification of compounds. In addition, the CART (classification and regression trees) method was used for construction of decision trees and finding the best molecular descriptors. The results revealed that the developed CPANN models and decision tree can correctly classify the molecules according to their inhibition mechanisms and activities. Some general parameters such as molecular weight, average molecular weight, number of hydrogen atoms and number of hydroxyl groups were found to be important for describing the inhibition behaviour of anti-HIV agents. The developed classifier models in this work can be used to screen large libraries of compounds to identify those likely to display activity as anti-HIV agents.Keywords
This publication has 49 references indexed in Scilit:
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)Antiviral Research, 2010
- Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitorsEuropean Journal of Medicinal Chemistry, 2009
- In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitorsEuropean Journal of Medicinal Chemistry, 2008
- From Docking False-Positive to Active Anti-HIV AgentJournal of Medicinal Chemistry, 2007
- Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivativesSAR and QSAR in Environmental Research, 2006
- Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA)Antiviral Research, 2005
- HIV-chemotherapy and -prophylaxis: new drugs, leads and approachesThe International Journal of Biochemistry & Cell Biology, 2004
- Comparative study of non nucleoside inhibitors with HIV-1 reverse transcriptase based on 3D-QSAR and dockingSAR and QSAR in Environmental Research, 2003
- Automated Docking and the Search for HIV Protease InhibitorsSAR and QSAR in Environmental Research, 1998
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983